Clinical trials
Emphysema trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Brompton & Harefield NHS Foundation Trust | 4 |
| Temple University | 3 |
| Heidelberg University | 2 |
| LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology | 2 |
| Rabin Medical Center | 2 |
| Andalusian School of Public Health | 1 |
| Arda Kiani | 1 |
| Asan Medical Center | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 41 |
| Pulmonary Disease, Chronic Obstructive | 30 |
| Bronchitis, Chronic | 4 |
| Bronchiectasis | 3 |
| Pulmonary Fibrosis | 3 |
| alpha 1-Antitrypsin Deficiency | 3 |
| Asthma | 2 |
| Cystic Fibrosis | 2 |
| Lung Diseases | 2 |
| Pulmonary Emphysema | 2 |
Trials
Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.